Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
Haematologica|April 16, 2017
Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker ConsortiumWendy B C Stevens, Matias Mendeville, Robert Redd, et al.
Hemasphere|May 4, 2026
Dissecting minimal residual disease dynamics to improve outcome prediction in mantle cell lymphoma: Data from the Fondazione Italiana Linfomi (FIL)-MCL0208 clinical trialFrancesca Cordero, Simone Ferrero, Simone Pernice, et al.
Blood|November 20, 2016
B-cell receptor-driven MALT1 activity regulates MYC signaling in mantle cell lymphomaBeiying Dai, Michael Grau, Mélanie Juilland, et al.
Blood|December 25, 2009
Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup studyChristiane Pott, Eva Hoster, Marie-Helene Delfau-Larue, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2016
Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma NetworkEva Hoster, Andreas Rosenwald, Françoise Berger, et al.
Leukemia|August 10, 2023
Novel insights into the pathogenesis of follicular lymphoma by molecular profiling of localized and systemic disease formsSabrina Kalmbach, Michael Grau, Myroslav Zapukhlyak, et al.
Blood Cancer Journal|April 24, 2025
Validation of POD24 as a robust early clinical indicator of poor survival in mantle cell lymphoma from 1280 patients on clinical trials, a LYSA studyClémentine Sarkozy, Loïc Chartier, Vincent Ribrag, et al.
Cancers|January 11, 2022
A Clinical Prognostic Model Based on Machine Learning from the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III TrialGian Maria Zaccaria, Simone Ferrero, Eva Hoster, et al.
Blood|June 1, 2012
GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemiaPhilipp A Greif, Annika Dufour, Nikola P Konstandin, et al.
Journal of Hematopathology|August 12, 2009
Ki-67 as a prognostic marker in mantle cell lymphoma-consensus guidelines of the pathology panel of the European MCL NetworkWolfram Klapper, Eva Hoster, Olaf Determann, et al.
Pageof 11